FDA’s Center for Drug Evaluation and Research (CDER) has announced the new Quantitative Medicine (QM) Center of Excellence (CoE).
QM involves the development and application of exposure-based, biological, and quantitative modeling and simulation approaches derived from nonclinical, clinical, and real-world sources to inform drug development, regulatory decision-making, and patient care. The goal of this CDER-wide CoE is to facilitate and coordinate the continuous evolution and consistent application of QM across the center.
On April 25, CDER will host a public workshop on QM and will share more about the new CoE. To register, please visit Streamlining Drug Development and Improving Public Health through Quantitative Medicine: An Introduction to the CDER Quantitative Medicine Center of Excellence.
Subscribe to our e-Newsletters
Stay up to date with the latest news, articles, and events. Plus, get special offers
from American Pharmaceutical Review – all delivered right to your inbox!
Sign up now!